Gatekeeping hormone replacement therapy for transgender patients is dehumanising
Gatekeeping hormone replacement therapy for transgender patients is dehumanising
复制标题
DOI：
10.1136/medethics-2018-105293
复制
发表时间：
2019-07-01
影响因子：
4.1
通讯作者：
Ashley, Florence
中科院分区：
文献类型：
--
作者：
Ashley, Florence
尽管用于开具激素替代疗法处方的知情同意模式正变得越来越普遍，但许多医生仍然需要在开处方前获得心理健康专业人员的评估和转介信。根据个人和社区的经验，作者认为，评估和转诊要求是非人性化和不道德的，突出了这些要求证明对跨性别者不信任的方式，抑制了他们经历的多样性，并与其他形式的临床护理相比，维持了不合理的双重标准。医生应该放弃这种不道德的要求，转而采用知情同意的方法来治疗变性人。
Although informed consent models for prescribing hormone replacement therapy are becoming increasingly prevalent, many physicians continue to require an assessment and referral letter from a mental health professional prior to prescription. Drawing on personal and communal experience, the author argues that assessment and referral requirements are dehumanising and unethical, foregrounding the ways in which these requirements evidence a mistrust of trans people, suppress the diversity of their experiences and sustain an unjustified double standard in contrast to other forms of clinical care. Physicians should abandon this unethical requirement in favour of an informed consent approach to transgender care.